Effector Therapeutics Company

eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).

Headquarters: United States
Employee Number: 11-50
Industry: Genomic and Epigenominc Instabillity
Technology: Others
Estimated Revenue: $10M to $50M
Founded Date: 2012